Insider Transactions in Q4 2022 at Prothena Corp Public LTD CO (PRTA)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
10,000
-46.02%
|
$580,000
$58.83 P/Share
|
|
Dec 21
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+43.1%
|
$60,000
$6.73 P/Share
|
|
Dec 12
2022
|
Shane Cooke |
SELL
Open market or private sale
|
Direct |
5,000
-41.12%
|
$300,000
$60.14 P/Share
|
|
Dec 12
2022
|
Shane Cooke |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$30,000
$6.41 P/Share
|
|
Dec 05
2022
|
Richard T Collier |
SELL
Open market or private sale
|
Direct |
5,000
-27.15%
|
$310,000
$62.59 P/Share
|
|
Dec 05
2022
|
Richard T Collier |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+44.57%
|
$30,000
$6.41 P/Share
|
|
Dec 01
2022
|
Lars Ekman |
SELL
Open market or private sale
|
Direct |
15,834
-78.58%
|
$965,874
$61.7 P/Share
|
|
Dec 01
2022
|
Lars Ekman |
BUY
Exercise of conversion of derivative security
|
Direct |
15,834
+49.62%
|
$95,004
$6.41 P/Share
|
|
Dec 01
2022
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-100.0%
|
$248,000
$62.51 P/Share
|
|
Dec 01
2022
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$96,000
$24.9 P/Share
|
|
Nov 30
2022
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-47.79%
|
$310,000
$62.96 P/Share
|
|
Nov 30
2022
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$50,000
$10.27 P/Share
|
|
Nov 23
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
10,000
-37.32%
|
$610,000
$61.36 P/Share
|
|
Nov 23
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+43.1%
|
$60,000
$6.73 P/Share
|
|
Nov 18
2022
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
10,000
-98.87%
|
$570,000
$57.66 P/Share
|
|
Nov 18
2022
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$150,000
$15.04 P/Share
|
|
Nov 10
2022
|
Shane Cooke |
SELL
Open market or private sale
|
Direct |
5,000
-62.22%
|
$275,000
$55.73 P/Share
|
|
Nov 10
2022
|
Shane Cooke |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$30,000
$6.41 P/Share
|
|
Nov 07
2022
|
Richard T Collier |
SELL
Open market or private sale
|
Direct |
5,000
-40.36%
|
$275,000
$55.78 P/Share
|
|
Nov 07
2022
|
Richard T Collier |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+44.57%
|
$30,000
$6.41 P/Share
|
|
Nov 01
2022
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-93.61%
|
$248,000
$62.12 P/Share
|
|
Nov 01
2022
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$96,000
$24.9 P/Share
|
|
Nov 01
2022
|
Lars Ekman |
SELL
Open market or private sale
|
Direct |
15,833
-58.09%
|
$997,479
$63.53 P/Share
|
|
Nov 01
2022
|
Lars Ekman |
BUY
Exercise of conversion of derivative security
|
Direct |
15,833
+49.62%
|
$94,998
$6.41 P/Share
|
|
Oct 27
2022
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
20,000
-100.0%
|
$1,240,000
$62.0 P/Share
|
|
Oct 27
2022
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$200,000
$10.27 P/Share
|
|
Oct 26
2022
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
65,000
-61.39%
|
$3,900,000
$60.25 P/Share
|
|
Oct 26
2022
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
65,000
+50.0%
|
$650,000
$10.27 P/Share
|
|
Oct 24
2022
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
20,000
-68.77%
|
$1,140,000
$57.74 P/Share
|
|
Oct 24
2022
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$300,000
$15.04 P/Share
|
|
Oct 19
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
10,000
-26.9%
|
$560,000
$56.7 P/Share
|
|
Oct 19
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+43.1%
|
$60,000
$6.73 P/Share
|
|
Oct 10
2022
|
Shane Cooke |
SELL
Open market or private sale
|
Direct |
5,000
-73.24%
|
$275,000
$55.88 P/Share
|
|
Oct 10
2022
|
Shane Cooke |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$30,000
$6.41 P/Share
|
|
Oct 05
2022
|
Richard T Collier |
SELL
Open market or private sale
|
Direct |
5,000
-29.74%
|
$290,000
$58.35 P/Share
|
|
Oct 05
2022
|
Richard T Collier |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+44.57%
|
$30,000
$6.41 P/Share
|
|
Oct 03
2022
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-100.0%
|
$240,000
$60.9 P/Share
|
|
Oct 03
2022
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$96,000
$24.9 P/Share
|
|
Oct 03
2022
|
Lars Ekman |
SELL
Open market or private sale
|
Direct |
15,833
-54.99%
|
$965,813
$61.61 P/Share
|
|
Oct 03
2022
|
Lars Ekman |
BUY
Exercise of conversion of derivative security
|
Direct |
15,833
+49.62%
|
$94,998
$6.41 P/Share
|